Iodoquinazoline-derived VEGFR-2 and EGFRT790M dual inhibitors: Design, synthesis, molecular docking and anticancer evaluations
AA Mohamed, SSA El-Hddad, AKB Aljohani… - Bioorganic …, 2024 - Elsevier
Herein, we report the synthesis of a series of new fourteen iodoquinazoline derivatives 7a-c
to 13a-e and their evaluation as potential anticancer agents via dual targeting of EGFR …
to 13a-e and their evaluation as potential anticancer agents via dual targeting of EGFR …
Iodoquinazoline-derived VEGFR-2 and EGFRT790M dual inhibitors: Design, synthesis, molecular docking and anticancer evaluations
AA Mohamed, SSA El-Hddad, AKB Aljohani… - Bioorganic … - pubmed.ncbi.nlm.nih.gov
Herein, we report the synthesis of a series of new fourteen iodoquinazoline derivatives 7a-c
to 13a-e and their evaluation as potential anticancer agents via dual targeting of EGFR …
to 13a-e and their evaluation as potential anticancer agents via dual targeting of EGFR …
Iodoquinazoline-derived VEGFR-2 and EGFRT790M dual inhibitors: Design, synthesis, molecular docking and anticancer evaluations.
AA Mohamed, SSA El-Hddad, AKB Aljohani… - Bioorganic …, 2023 - europepmc.org
Herein, we report the synthesis of a series of new fourteen iodoquinazoline derivatives 7a-c
to 13a-e and their evaluation as potential anticancer agents via dual targeting of EGFR …
to 13a-e and their evaluation as potential anticancer agents via dual targeting of EGFR …